Dietary fish oil preserves cardiac function in the hypertrophied rat heart

British Journal of Nutrition

Volumn 108, Issue 4, 2012, Pages 645-654

  McLennan, Peter L ^a   Abeywardena, Mahinda Y ^b   Dallimore, Julie A ^b   Raederstorff, Daniel ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b CSIRO   (Australia)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Diet; Fish oil; Heart failure; Hypertrophy; n 3 Fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; OLIVE OIL; OMEGA 3 FATTY ACID;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; ENERGY; FAT INTAKE; FISH; FOOD INTAKE; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART OUTPUT; HEART PROTECTION; HEART WORK; INCIDENCE; ISOLATED HEART; MALE; NONHUMAN; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; RAT; SHAM PROCEDURE; WISTAR RAT;

ANIMALS; AORTA, ABDOMINAL; CARDIAC OUTPUT; CARDIOMEGALY; CARDIOTONIC AGENTS; CONSTRICTION; CORONARY CIRCULATION; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; FISH OILS; HEART; HEART FAILURE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84865238259     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005915     Document Type: Article

References (53)

1. Najafi F, Jamrozik K & Dobson AJ (2009) Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure. Eur J Heart Fail 11, 472-479.
2. Bucher HC, Hengstler P, Schindler C, et al. (2002) n-3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112, 298-304. (Pubitemid 34219443)
3. Mozaffarian D, Ascherio A, Hu FB, et al. (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111, 157-164. (Pubitemid 40139726)
4. McLennan PL, Abeywardena MY & Charnock JS (1988) Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 116, 709-717.
5. Siscovick DS, Raghunathan TE, King I, et al. (1995) Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274, 1363-1367.
6. Marchioli R, Barzi F, Bomba E, et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione. Circulation 105, 1897-1903. (Pubitemid 34437615)
7. Mozaffarian D, Bryson CL, Lemaitre RN, et al. (2005) Fish intake and risk of incident heart failure. J Am Coll Cardiol 45, 2015-2021. (Pubitemid 40814125)
8. Valagussa F, Franzosi MG, Geraci E, et al. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Lancet 354, 447-455.
9. Nordoy A, Marchioli R, Arnesen H, et al. (2001) n-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids 36, S127-S129. (Pubitemid 34106222)
10. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757-761. (Pubitemid 19234807)
11. al Makdessi S, Brandle M, Ehrt M, et al. (1995) Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids. Mol Cell Biochem 145, 69-73.
12. Pepe S & McLennan PL (1996) Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr 126, 34-42. (Pubitemid 26030631)
13. Pepe S & McLennan PL (2002) Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and post-ischemic recovery of contractile function. Circulation 105, 2303-2308. (Pubitemid 34535342)
14. McLennan PL & Abeywardena MY (2005) Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Memb Biol 206, 85-102. (Pubitemid 43199143)
15. McLennan P, Howe P, Abeywardena M, et al. (1996) The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 300, 83-89. (Pubitemid 26130477)
16. Abdukeyum GG, Owen AJ & McLennan PL (2008) Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr 138, 1902-1909.
17. Demaison L & Grynberg A (1994) Cellular and mitochondrial energy metabolism in the stunned myocardium. Basic Res Cardiol 89, 293-307. (Pubitemid 24350553)
18. Mettauer B, Zoll J, Garnier A, et al. (2006) Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflug Arch 452, 653-666. (Pubitemid 44337900)
19. Ormerod JOM, Ashrafian H & Frenneaux MP (2008) Impaired energetics in heart failure - a new therapeutic target. Pharmacol Ther 119, 264-274.
20. Reibel DK, O'Rourke B, Foster KA, et al. (1986) Altered phospholipid-metabolism in the pressure-overload hypertrophied hearts. Am J Physiol 250, H1-H6.
21. Duda MK, O'Shea KM, Lei B, et al. (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76, 303-310. (Pubitemid 350198598)
22. Siddiqui RA, Shaikh SR, Kovacs R, et al. (2004) Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. J Cell Biochem 92, 1141-1159. (Pubitemid 44264224)
23. Slee EL, McLennan PL, Owen AJ, et al. (2010) Low dietary fish oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J Lipid Res 51, 1841-1848.
24. Duda MK, O'Shea KM, Tintinu A, et al. (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81, 319-327.
25. Takahashi R, Okumura K, Asai T, et al. (2005) Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res 68, 213-223. (Pubitemid 41428418)
26. Traverse JH, Chen Y, Crampton M, et al. (2001) Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure. Cardiovasc Res 52, 454-461. (Pubitemid 33153108)
27. Siddiqui RA, Harvey KA & Zaloga GP (2008) Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 19, 417-437. (Pubitemid 351783409)
28. 2+ activation of PDH. Am J Physiol 276, H149-H158. (Pubitemid 29065633)
29. Hallaq H, Sellmayer A, Smith TW, et al. (1990) Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci 87, 7834-7838.
30. 2+ handling in adult rat cardiomyocytes. J Nutr Biochem 12, 365-376. (Pubitemid 32552053)
31. McLennan PL (2001) Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36, S111-S114. (Pubitemid 34106219)
32. Sexton PT, Sinclair AJ, O'Dea K, et al. (1995) The relationship between linoleic acid level in serum, adipose tissue and myocardium in humans. Asia Pacific J Clin Nutr 4, 314-318. (Pubitemid 126015610)
33. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327-335. (Pubitemid 350198856)
34. Mozaffarian D, Geelen A, Brouwer IA, et al. (2005) Effect of fish oil on heart rate in humans - a metaanalysis of randomized controlled trials. Circulation 112, 1945-1952. (Pubitemid 41377412)
35. Yokoyama M, Origasa H, Matsuzaki M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. Lancet 369, 1090-1098. (Pubitemid 46483662)
36. Abeywardena MY & Charnock JS (1995) Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat. Lipids 30, 1151-1156.
37. Abeywardena MY, McLennan PL & Charnock JS (1991) Changes in myocardial eicosanoid production following long-term dietary lipid supplementation in rats. Am J Clin Nutr 53, 1039S-1041S. (Pubitemid 21898870)
38. Novak F, Kolar F, Hamplova B, et al. (2009) Myocardial phospholipid remodeling under different types of load imposed during early postnatal development. Physiol Res 58, S13-S32.
39. Gudbjarnason S, Benediktsdottir VE & Skuladottir G (1989) Effects of n-3 polyunsaturated fatty acids on coronary heart disease. Bibliotheca Nutritio et Dieta 43, 1-12.
40. 2 cost of catecholamines in heart failure). Eur J Heart Fail 6, 409-419. (Pubitemid 38746583)
41. Katz AM (1986) Potential deleterious effects of inotropic agents in the therapy of chronic heart-failure. Circulation 73, 184-190.
42. Lubic SP, Giacomini KM & Giacomini JC (1995) The effects of modulation of calcium influx through the voltage-sensitive calcium-channel on cardiomyocyte hypertrophy. J Mol Cell Cardiol 27, 917-925.
43. Eichhorn EJ & Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94, 2285-2296. (Pubitemid 26360526)
44. Kim S, Yoshiyama M, Izumi Y, et al. (2001) Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103, 148-154. (Pubitemid 32050450)
45. Nagatsu M, Spinale FG, Koide M, et al. (2000) Bradycardia and the role of b-blockade in the amelioration of left ventricular dysfunction. Circulation 101, 653-659. (Pubitemid 30094737)
46. Reibel DK, Holahan MA & Hock CE (1988) Effects of dietary fish oil on cardiac responsiveness to adrenoceptor stimulation. Am J Physiol 254, H494-H499.
47. Levitan EB, Wolk A & Mittleman MA (2009) Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middleaged and elderly men. Eur Heart J 30, 1495-1500.
48. Tavazzi L, Maggioni AP, Marchioli R, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230.
49. Ghio S, Scelsi L, Latini R, et al. (2010) Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 12, 1345-1353.
50. McLennan PL, Owen AJ, Slee EL, et al. (2007) Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis. J Cardiovasc Med 8, Suppl. 1, S15-S18. (Pubitemid 47429075)
51. Mozaffarian D & Rimm EB (2006) Fish intake, contaminants, and human health - evaluating the risks and the benefits. JAMA 296, 1885-1899. (Pubitemid 44596197)
52. Owen AJ, Peter-Przyborowska BA, Hoy AJ, et al. (2004) Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39, 955-961. (Pubitemid 40095878)
53. Pepe S & McLennan P (2007) (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr 137, 2377-2383. (Pubitemid 350058704)